** Shares of SomnoMed Ltd SOM.AX fall 12.3% to A$0.465, their lowest levels since January 20
** The medical device maker plans to absorb the costs associated with the tariff changes in the immediate term and reiterates FY25 outlook for revenue and EBITDA
** Co imports its products to the U.S. and manufactures them primarily in the Philippines
** Stock posts biggest percentage drop since December 16
** Stock sees busiest session since early February
** Stock up 1.1% YTD, including moves in current session
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。